2006 Research
2008 Research
2007
Research
2006
Research
2005
Research
2004-2001 Research Archives
October 2006
New Alternative Against Cirrhosis
Cirrhosis goes for the throat
Acetaminophen at Recommended Doses Elevates Alanine
Aminotransferase Levels
Spleen Removal Can Help Hepatitis C Patients
with Cirrhosis Tolerate Treatment
Some Prescriptions Can Lead to Chronic
Drug-Induced Liver Injury
Cirrhosis and Chronic Liver Failure Diagnosis and
Evaluation
Cirrhosis and Chronic Liver Failure Complications and
Treatment
Explaining Cirrhosis
August
Long-term Effect of
Interferon/Ribavirin on Incidence of Hepatocellular Carcinoma
Diabetes is Associated with Hepatic Encephalopathy in
Patients with HCV-Related Cirrhosis
Coffee, Cirrhosis, and Transaminase Enzymes
Gallstones in liver cirrhosis
Diabetes Worsens Encephalopathy
HCV RNA detection by TMA during the hepatitis C antiviral long-term
treatment against cirrhosis (Halt-C) trial
-
(08/01/06)
Hepatitis C Virus Detection Using HCV
RNA Qualitative (TMA) Testing in the HALT-C TrialNatural
History of Liver Cirrhosis Due to Hepatitis C
Promising Data on Consensus Interferon Retreatment of
Relapsers and Non-Responders
Insulin Resistance and Diabetes in Patients with
Chronic Hepatitis C
Pre-transplant
TACE Therapy Response May Help Select Liver Transplant Recipients
HCC and Non-Liver Cancers in People with Cirrhosis
June 06 06
Abstract M1210 – Diabetes mellitus worsens the clinical outcome of acute
variceal bleed in cirrhotic patients
6-6-06
Abstract M1214 – Nonabsorbed (< 0.4%) Antibiotic
Rifaximin Improves Hepatic Encephalopathy
Symptoms in Patients With Cirrhosis Due to Hepatitis C
6-6-06
S1583. Green Tea Polyphenols Attenuate
Acetaminophen Hepatotoxicity.
Abstract T1047 – Initial HCV Response in Patients with End Stage Renal
Disease treated with Combination Pegylated Interferon α-2a and Ribavirin
6-6-06
Impact of Alcohol Use on Hepatitis C Treatment
Outcomes and Quality of Life
The
Effect of Liver Fibrosis and Cirrhosis on SVR in 4913 Patients with
Hepatitis C: Results from the Win-R Trial
-
M1032 - The occurrence of malignancy in patients with liver cirrhosis-more
than HCC
Metabolics/Belly Fat Advance HCV Disease
5/23/06
Retreatment with Peginterferon Alfa-2a
(Pegasys) Plus Ribavirin of Nonresponders with Cirrhosis/Advanced Fibrosis
to Peginterferon Alfa-2b (PegIntron)
- 5/23/06
Initial HCV Response in Patients with End Stage Renal Disease Treated
with Pegasys Plus Ribavirin
Celera To Announce Test For Cirrhosis In Hepatitis C
Patients
Entecavir Improved Fibrosis in Advanced Liver Disease More Than Lamivudine
in 3 Pivotol Studies After 48 Weeks Therapy
Encephalopathy and Liver Disease/Hepatitis
Coffee and tea intake may lower chronic liver disease risk
Nutrition and
cirrhosis
HCV RNA Predicts Death from
End Stage Liver Disease
CIRRHOSIS IN CHRONIC
HEPATITIS C INFECTION
Liver Cirrhosis- and Hepatitis C Virus-related
Brain Disease
-
Cirrhosis and Chronic Liver Failure Diagnosis and
Evaluation
Cirrhosis and Chronic Liver Failure Complications and
Treatment
Explaining Cirrhosis
|
